ArticleiScience2026
Obesity mediates the association of outdoor artificial light at night with type 2 diabetes mellitus.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to explore the association of outdoor ALAN exposure with T2DM and the mediating effects of obesity in Chinese rural adults. A total of 38,108 participants were recruited from the Henan Rural Cohort. ALAN was positively associated with T2DM and FPG, and negatively associated with insulin, HOMA-IR, as well as HOMA-β, and the effect sizes of per-quartile increase in ALAN were 1.24(1.19, 1.28), 0.14(0.13, 0.16), -1.19(-1.24, -1.14), -0.22(-0.25, -0.20), and -27.30(-29.11, -25.48), respectively. The elderly, men, current smokers, individuals with lower education or income, or physical inactivity were more vulnerable to ALAN-related adverse health effects. The associations of ALAN with T2DM and glucose metabolism were mediated by WC, BMI, WHtR, WHR, VFI, and BFP, with estimated mediation proportions of 36.41%, 25.14%, 33.98%, 22.33%, 24.39%, and 25.85%, respectively, for T2DM. These findings emphasize the need for targeted public health interventions for reducing ALAN-related adverse health effects in rural areas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.